1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

18 Dec 2025
Admin
News Article

Merz Aesthetics Launches XEOMIN and RADIESSE in China, Expanding Its Global Injectables Footprint

Merz Aesthetics has officially launched XEOMIN® and RADIESSE® in China, marking a major expansion into the world’s fastest-growing medical aesthetics market.

The move strengthens Merz’s position as the world’s largest dedicated medical aesthetics company and brings two of its flagship injectables to Chinese patients and practitioners.

Why China Matters for Merz Aesthetics?

China’s medical aesthetics market is evolving fast. Demand is rising for treatments that deliver natural-looking results, proven safety, and long-term value.

By entering this market, Merz Aesthetics aims to:

Extend access to globally trusted injectables
Support practitioners with clinically validated solutions
Meet growing patient expectations around safety and customization

This launch signals Merz’s long-term commitment to the region.

XEOMIN: A Differentiated Neurotoxin Offering

XEOMIN stands apart from traditional botulinum toxins.

Key features include:

Double-purified formulation using XTRACT Technology™
Removal of unnecessary proteins and inactive ingredients
Only the active neurotoxin plus two non–immune-triggering components

In pivotal clinical studies, XEOMIN has shown zero toxin resistance, a key advantage for long-term aesthetic treatment planning.

RADIESSE: A Proven Biostimulator in Regenerative Aesthetics

RADIESSE is widely recognized in regenerative aesthetics research.

What makes it distinctive:

Microspheres that activate through non-inflammatory pathways
Uses calcium hydroxylapatite, a substance naturally found in the body
Stimulates the skin’s own regenerative processes

Clinical data shows RADIESSE can:

Boost collagen production by up to 23 times
Increase elastin production by 96%

This positions RADIESSE as a strong option for patients seeking gradual, biologically driven aesthetic improvement.

Beyond Products: Merz’s Strategy in China

Merz Aesthetics is not focusing on products alone.

According to Lawrence Siow, President of Merz Aesthetics Asia Pacific, the company is also investing in:

Practitioner education and hands-on training
Long-term partnerships with aesthetic clinics
Customized treatment approaches for diverse patient needs

The goal is to help practitioners deliver consistent, confident outcomes.

The Bigger Picture

With XEOMIN and RADIESSE now available in China, Merz Aesthetics is reinforcing its global strategy centered on:

Science-backed innovation
Patient-centric design
Sustainable growth in high-potential markets

As China’s aesthetics sector continues to mature, Merz is positioning itself as a long-term partner to both clinicians and patients.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!